Business
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure of the 2024 Annual Report
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure of the 2024 Annual Report
About this update from Qinghai Spring Medicinal Resources Technology Co.,ltd. Class A
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure of the 2024 Annual ReportThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment